78 related articles for article (PubMed ID: 11143573)
1. Clarification needed for raloxifene use.
Reinders M
Can Fam Physician; 2000 Nov; 46():2185. PubMed ID: 11143573
[No Abstract] [Full Text] [Related]
2. [Raloxifene: a new molecule for the prevention of menopausal osteoporosis].
Oliaro A
Minerva Ginecol; 1998 Mar; 50(3):XII-XIII. PubMed ID: 9595915
[No Abstract] [Full Text] [Related]
3. Why is the RUTH trial so important?
Pines A; Levo Y
Maturitas; 2007 Feb; 56(2):111-2. PubMed ID: 17092665
[No Abstract] [Full Text] [Related]
4. Effect of raloxifene on urinary incontinence: a randomized controlled trial.
Lowder JL; Weber AM
Obstet Gynecol; 2004 Jul; 104(1):197-8; author reply 198. PubMed ID: 15229033
[No Abstract] [Full Text] [Related]
5. Postmenopausal HRT--a role for tamoxifen?
Jackson G
Int J Clin Pract; 1997; 51(5):267. PubMed ID: 9489081
[No Abstract] [Full Text] [Related]
6. Medications for postmenopausal osteoporosis prevention.
Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
[No Abstract] [Full Text] [Related]
7. Raloxifene and breast cancer.
Lorraine J
CMAJ; 2001 Oct; 165(7):888. PubMed ID: 11599326
[No Abstract] [Full Text] [Related]
8. Drug therapy for osteoporosis management in nursing home residents.
Lee VK; McCarthy MW
Lippincotts Prim Care Pract; 1999; 3(2):150-62. PubMed ID: 10426058
[No Abstract] [Full Text] [Related]
9. 'Smart' estrogens emerging.
Harv Heart Lett; 1998 Mar; 8(7):4-5. PubMed ID: 9516317
[No Abstract] [Full Text] [Related]
10. Smart estrogens may decrease heart-attack risk.
Harv Heart Lett; 1998 Sep; 9(1):2. PubMed ID: 9734243
[No Abstract] [Full Text] [Related]
11. Raloxifene and its role in breast cancer prevention.
Eng-Wong J; Zujewski JA
Expert Rev Anticancer Ther; 2004 Aug; 4(4):523-32. PubMed ID: 15270657
[TBL] [Abstract][Full Text] [Related]
12. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Wenger NK; Geiger MJ
Contemp Clin Trials; 2005 Dec; 26(6):612-5. PubMed ID: 16257585
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
Simoncini T; Mannella P; Genazzani AR
Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
[TBL] [Abstract][Full Text] [Related]
14. Drug information needs clarification.
Grossman LD
Can Fam Physician; 2001 Jan; 47():28-30. PubMed ID: 11212427
[No Abstract] [Full Text] [Related]
15. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and raloxifene activities on amyloid-beta-induced inflammatory reaction.
Thomas T; Bryant M; Clark L; Garces A; Rhodin J
Microvasc Res; 2001 Jan; 61(1):28-39. PubMed ID: 11162193
[TBL] [Abstract][Full Text] [Related]
17. [Evidence-based medicine and drug selection of osleoporosis prevention after menopause].
Xu L
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):265-6. PubMed ID: 15059503
[No Abstract] [Full Text] [Related]
18. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Romero M
Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
[No Abstract] [Full Text] [Related]
19. [New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
Kammerer S
MMW Fortschr Med; 2003 Dec; 145(50):4-6. PubMed ID: 14963962
[No Abstract] [Full Text] [Related]
20. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study.
Cicinelli E; Pinto V; Tinelli R; Saliani N; De Leo V; Cianci A
Fertil Steril; 2007 Sep; 88(3):698-701. PubMed ID: 17678902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
